The first group was dubbed "gram-positive," while the latter was designated "gram-negative." Related: Dangerous 'superbugs' are a growing threat, and antibiotics can't stop their rise. What can?

The EU-CORE study included patients who had received at least 1 dose of daptomycin between January 2006 and April 2012 for the treatment of a serious Gram-positive bacterial infection. Patients ...

today announced the submission of its Accelerate WAVE™ system and positive blood culture gram-negative test kit to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The ...